Cells sense and respond to their environment by activating distinct intracellular signaling pathways, however signal transmission in individual cells is not well understood. To assess the accuracy of signal transmission in individual cells, we developed an optimized genetically encoded sensor for IGF-I signaling. We stably expressed this sensor in HeLa cells and used live-cell imaging to monitor dynamic responses to IGF-I in individual cells. Across the population, signaling responses overlapped between different IGF-I doses, suggesting limited transmission accuracy. However, analysis of individual cell traces revealed relatively constant responses over time. An information theoretic approach to calculate the channel capacity using variance of the single cell time course data--rather than population data--predicted that cells were capable of discriminating multiple growth factor doses. We validated these predictions by tracking individual cell responses to multiple IGF-I doses and found that cells can accurately distinguish at least four different IGF-I concentrations, and also that the input-output relation varies across the population of individual cells. Furthermore, by monitoring responses to the PI3K inhibitor alpelisib we found a similar discriminatory ability to pathway inhibition. Our studies indicate that heterogeneous responses to IGF-I arise from cells encoding the growth factor input into different signaling outputs and that individual cells can accurately sense and respond to a range of stimuli of varying strengths. These observations reveal the importance of viewing each cell as having its own communication channel and underscore the importance of understanding responses at the single cell level.
Introduction
Cells sense and respond to their local environment by activating distinct intracellular signaling pathways. These pathways are composed of multi-step relays that use second messengers, protein translocations, and kinase/phosphatase cycles to encode, relay, and decode the extracellular signal into an intracellular response 1 . Given the multi-step nature of cell signaling in both space and time, much remains unknown about exactly how individual cells process extracellular signals into accurate intracellular responses [2] [3] [4] [5] . Previous studies have observed that cell signaling is inherently noisy and that individual cells are limited in their detection of extracellular stimuli [2] [3] [4] , which suggests that ensemble averaging across the population is required to faithfully decode extracellular signals into accurate signaling responses. However, these studies assessed signaling pathways with predominantly pulsatile--rather than sustained-responses, which hinders the ability to quantify and compare individual cell responses across time, and may also obscure alternate explanations for heterogeneity.
The IGF-I -PI3K -AKT signaling pathway provides an excellent model to study cell signaling: it uses multiple modalities to encode, relay, and decode extracellular signals, and also produces sustained responses. In brief, IGF-I binds to the receptor tyrosine kinase IGF1R to stimulate intracellular kinase activity 6 . This leads to recruitment of protein binding partners and translation of the protein signal into a lipid second messenger by PI3-Kinase and the subsequent phosphorylation and activation of AKT. The protein kinase AKT can then phosphorylate a range of proteins including the transcription factor FoxO1 [6] [7] [8] [9] . Previously, we developed a fluorescent fusion protein using FoxO1, which can be used as a readout for IGF-I signaling activity 10 , and found that responses to IGF-I were sustained across time but heterogeneous across the population. We surmised that this heterogeneity could arise from various sources including: noise in the signaling pathway, variability in the reporter and its quantification, non-specificity in the reporter, or variation in the encoding of the signal between cells.
Transitions from healthy to diseased states involve changes to cell signaling, therefore a deep understanding of the fidelity of signaling in individual cells will provide insights into disease progression and treatment. For example, cancers arise from genetic alterations that drive activation of oncogenic pathways such as the PI3K-AKT pathway [11] [12] [13] . Moreover, cancers are frequently marked by substantial intratumoral heterogeneity 14 , indicating the need to quantify signaling at the single cell level. Several small molecule inhibitors have been developed to inhibit PI3K-AKT pathway activity and block cancer growth 15 . While promising, responses to these compounds are variable and resistance inevitably develops 16, 17 . One possible explanation for incomplete therapeutic responses is variation in the signaling capability of individual cells [18] [19] [20] . We therefore propose that more complete understanding of responses to pathway-targeted activators and inhibitors at the single cell level will influence how clinical responses are interpreted and can also inform mechanisms of drug resistance.
Here we report the development of an improved FoxO1 reporter to monitor AKT activity in individual cells and use it to assess noise in growth factor signaling. In genetically transformed HeLa cells, we observed heterogeneous responses to IGF-I that were consistent with individual cells having different input-output relationships. To account for differences in the input-output relation across the population, we calculated the channel capacity-which provides an assessment of signaling fidelity-by measuring variance in individual cells over a time window when signaling responses had stabilized. This approach nearly doubled the predicted number of IGF-I doses a cell could accurately discriminate. We then experimentally validated these predictions by treating cells with multiple IGF-I doses and showed that individual cells could accurately discriminate at least four IGF-I concentrations. Furthermore, we found that signaling fidelity extends to pathway inhibition such that the level of activation is largely correlated with the level of inhibition. We conclude that single cell responses to submaximal doses of IGF-I vary across a population because individual cells have different input-output relationships, and further that accounting for these differences reveals high signaling fidelity in individual cells.
RESULTS

Construction of a novel FoxO1 reporter with increased specificity
Signaling responses in the AKT, Erk, NF-kB, TRAIL and Ca 2+ pathways have been shown to be heterogeneous across the population [2] [3] [4] [5] 21 . This heterogeneity is frequently interpreted as arising from noise in signal transmission [2] [3] [4] . In previous work, we developed a live-cell reporter to study IGF-I responses at the single cell level: a fluorescently tagged FoxO1 protein 10 , which contains three AKT phosphorylation sites that regulate protein localization to the nucleus or cytoplasm depending on their phosphorylation status 9, 22 (Fig. 1A) . We found that the relative fraction of the reporter in the nucleus was variable across a population of HeLa cells cultured in serum free conditions 21 . We speculated that this variation resulted from phosphorylation on other non-AKT phosphorylation sites. In order to assess the signaling accuracy in the IGF-PI3K-AKT pathway, we first sought to eliminate non-specificity in our readout for pathway activity.
To construct a new reporter with increased specificity, we started from the template of the previously developed reporter, termed Fox Tracer 1 (FT1) and made alanine substitutions to 10 serine and threonine sites previously identified as phosphorylation sites of other kinases [23] [24] [25] [26] [27] (Fig.   1A and Supplementary Fig. 1A, B ). To reduce the protein size and eliminate other potential sources of non-specificity, we deleted a 234 amino acid segment from the C-terminus. Lastly, to increase the ease and efficiency of creating stable cell lines, we transferred the reporter from a lentiviral to a transposase delivery system 28 (Sup. Fig. 1C ).
The first construct we tested, FT2-LAP, under serum free conditions had a significantly reduced variance and increased nuclear localization compared to FT1, which suggests an increase in specificity from the alanine mutations. However, this increased specificity came at the cost of a reduced export rate following IGF-I treatment, which limits the ability to rapidly assess responses. We next tested a series of mutations around S326, which is located in an AKT phosphorylation domain thought to regulate the rate of FoxO1 nuclear export by creation of a negatively charged region when phosphorylated 26, 29 (Fig. 1B) . The single mutation of alanine 326 back to serine (FT2-LSP) increased the rate of nuclear export, but also added back a DYRK1/Erk phosphorylation site 26, 29 (Fig. 1D , Sup. Fig. 1D ). To eliminate this unwanted phosphorylation site, we mutated the peptide segment using the phosphomimetic amino acid aspartic acid. Furthermore, based on the concept that multiple negative charges better mimic the effect from phosphorylation 30, 31 , we tested four reporter variants that differed in the number of aspartic acid substitutions. A comparison of these variants revealed that response rates increase with peptide charge, leading to a maximum rate of export for the FT2-DDD reporter As a control for the FT2-DDD reporter, we created a mutant with the three AKT phosphorylation sites Thr24, Ser253 and Ser316 all mutated to alanine. As expected, this reporter (FT2-DDD 3A) does not translocate in response to IGF-I, which indicates that FT2-DDD responses to IGF-I are dependent on the AKT phosphorylation sites (Fig. 1D ). Comparing the FT1 to the FT2-DDD reporter, we found that FT2-DDD is the optimal reporter for tracking the accuracy of IGF-I signaling responses based on its: increased specificity ( Fig. 1A, B ), reduced population variance in both serum free conditions and following IGF-I treatment (Sup. Fig. 1E ), and increased measurement range ( Fig. 1F ).
Responses to IGF-I stimulation are heterogeneous across the population
We next used the optimized FT2-DDD reporter to quantify responses of individual cells to IGF-I.
As expected, we found a progressive increase in the average population response with increasing IGF-I dose, which was quantified as a change in the relative nuclear intensity of the fluorescent reporter in individual HeLa cells ( Fig. 2A and B ). Analysis of individual cells revealed heterogeneous responses to single doses of IGF-I and overlapping responses across multiple IGF-I doses, which has been interpreted as an inability of individual cells to discriminate different ligand doses 2 (Fig. 2C ). Importantly, this heterogeneity was not due to differences in the relative expression of the reporter between cells, nor differences in the basal level of activation in individual cells (Sup. Fig. 2 ). Thus, despite elimination of non-specificity in the readout for pathway activity, we find that responses to IGF-I are heterogeneous across a population of individual cells.
Integration of multiple time points to quantify a cell's response has been shown to reduce the level of heterogeneity by reducing measurement noise 3 . To measure the effect of varying the number of measurements for each response, we compared dose-response relationships using either one image, which corresponds to the fluorescence at 90 min (Raw), two images, which allows cell responses at 90 min to be normalized based on their starting value (T0 normalized), or 15 images, which incorporates the signal change over a longer time window (Summed). We found that the EC 50 values remained similar between measures ( Fig. 2D ), which indicating that the quantification method does not distort the relationship between doses. Comparison of the cell responses to 0, 15, 25, and 125 pM showed that overlap between the populations was reduced--but not eliminated--as the measurement window increased (Fig. 2D ). These observations indicate that single cell responses to IGF-I are heterogeneous, even with use of analytical approaches that reduce variance.
Responses of individual cells are stable across time
The Shannon-Hartley formula has been extensively used to quantify the signaling accuracy of biological systems [2] [3] [4] . A central assumption of the Shannon-Hartley channel capacity measurement, when applied to a population, is that the input-output relationship is identical for all cells in the population and observed variation is therefore attributed to noise in signal interpretation, transmission, and encoding. Based on this assumption, a noisy pathway would lead to large variation in single cell responses over time (Fig. 3A, upper) . Alternatively, there could be variation across the population in the input-output relationships of individual cells. In this case, we would expect to observe individual cells with minimal variation in signal transmission over time as well as heterogeneous responses across the population (Fig. 3A , lower). To separate these two scenarios, we quantified variation using the standard deviation of responses from each dose of IGF-I in the first 90-minute response window compared to the second 90-minute window when responses had reached a steady state ( Fig. 3B ). We found that the standard deviation during the first 90-minute response window increased as the dose of IGF-I increased ( Based on this interpretation, we hypothesized that variance quantified from stabilized responses provides a more robust calculation of noise for channel capacity measurements. To test this, we quantified channel capacity in various ways. Channel capacity calculated from a single time point yielded 1 bit ( Fig. 3D ), which is similar to prior measures of other signaling pathways 2 .
This measure was increased to 1.2 bits when we computed channel capacity from the T0 normalized responses (Fig. 3D ), and was further increased to 1.4 bits by using the summed responses drawn from 15 images. Finally, we quantified noise using the stable response window and found a channel capacity of 2.38 bits, which indicates that cells can discriminate at least 5 distinct IGF-I doses. While higher than previously reported, this is likely still an underestimate due to limitations in measuring individual cell responses. To test this idea, we treated cells with the nuclear export inhibitor Leptomycin B (LMB), which results in complete and sustained nuclear localization of the reporter. As a consequence, any variation in nuclear intensity after reaching steady state can be attributed to measurement noise rather than signaling noise. Comparison of how the signal varied across time for cells treated with LMB compared to cells treated with a submaximal dose of 17.5 pM IGF-I revealed nearly equivalent variances, which indicates that the true channel capacity may actually be much higher (Sup. Fig.   3B , C).
Individual cells can recapitulate population-derived dose response curves to reveal high signaling fidelity
To test the capacity of a single cell to discriminate different signal intensities, we treated cells with multiple doses of IGF-I spread across the dose response range. Treatment with single doses of IGF-I served as a reference control ( Fig. 4A ). We found that the average population response to a single dose matched the response from cells treated with the same dose as part of a multiple-dose treatment ( Fig. 4A ), with some decrement in the signal when cells were maintained in IGF-I (e.g., see late phase of 125 pM response). Likewise, population frequencies for multiple-dose treated cells were nearly equivalent to time-and dose-matched controls maintained with a single dose ( Fig. 4B ). Further analysis of these multiple-dose data reveal that it is possible to recapitulate a dose response curve from individual cells, and moreover that this dose response is similar to a traditional population-level dose response curve in which different cell populations were treated with escalating doses of IGF-I ( Fig. 4C ).
We next sought to assess whether individual cells could discriminate multiple IGF-I doses and whether all cells have equivalent input-output relationships. We tracked 400 single cell responses after multi-dose treatment (0, 17.5, 37.5, and 125 pM IGF-I) and found that individual cells show distinct responses to each IGF-I dose ( Fig. 5A , Movies 4-5). Moreover, we observed substantial variation across the population: some cells showed modest responses while others showed measurable responses to even the lowest dose tested. Comparison of traces from cells centered at the 25 th and 75 th percentiles revealed similar responses within the groupings but distinct differences between the groupings (Fig. 5B ). Likewise, the average dose response relationships from these cell subpopulations and a subpopulation of cells centered at the 50 th percentile revealed consistent responses within the groupings (Fig. 5C ), and moreover a cell's response to the first dose can be used to predict its response to the second dose (Sup. Fig. 4A ).
Finally, we find that responses of multi-dose treated cells are significantly different from timeand dose-matched cells maintained in the same dose (Sup. Fig. 4B ). These studies indicate that individual cells can discriminate a minimum of four distinct IGF-I concentrations, and the inputoutput relationship is consistent in individual cells but varies across the population.
Single cell responses to PI3Kα inhibition are influenced by IGF-I activation level
Our multi-dose single cell data indicate that cells can respond to multiple concentrations of IGF-I, and that a continuum of responses exists across the population due to different input-output relations. This raised the question of whether responses to pathway inhibition varies across the population of cells. To test this, we treated cells with 25 pM IGF-I, a submaximal dose that leads to high response variance (see Fig. 2B ), followed by dose escalation of the PI3Kα inhibitor alpelisib (0-500 nM). At the population level, we observed the expected dose-response relationship to alpelisib treatment ( Fig. 6A) . To understand single cell responses to alpelisib, we compared cells in the upper (blue traces) and lower (red traces) quantiles after treatment with 25 pM IGF-I. We found that these populations remain separable after inhibitor treatment ( Fig. 6 B, Movie 6), and that responses to PI3Kα inhibition were correlated with the level of activation from IGF-I ( Fig. 6C ). Comparison of all drug doses revealed similar separations between quantiles, up to 500 nM alpelisib, the dose at which signaling from IGF-I is nearly completely blocked ( Fig. 6D ). Together, these observations indicate that a cell's response to inhibition is determined by its response to IGF-I, and as a consequence, responses to pathway inhibition are in line with a model in which there is variation in how cells encode a signaling input.
Discussion
Understanding how individual cells respond to diverse stimuli is a fundamental issue in cell biology [32] [33] [34] . To that end, we describe here the development of a FoxO1 reporter with a higher specificity for IGF-I signaling compared to our previous FoxO1 reporter 10 . With this improved reporter, we observed that individual cell responses to IGF-I still overlapped between doses, suggesting low signaling fidelity. Further analysis showed that this overlap was from differences in how cells encode the signal, rather than from noise in the signaling pathway. Multi-dose treatment protocols validated these findings and showed that cells could accurately discriminate at least four different IGF-I doses. These studies demonstrate that individual cells can accurately process extracellular growth factors into downstream signaling responses despite having population responses that overlap between doses.
Reporter optimization for live cell imaging studies
Genetically encoded fluorescent reporters provide a powerful tool for understanding and quantifying dynamic signaling responses 35 . Various types of signaling reporters have been developed, including FRET sensors 36, 37 , synthetic translocation reporters 38 , and native proteins that translocate between the nucleus and cytoplasm (FoxO1 10, 39 , p53 40 , SMAD2 41 , NFkB 42 , Erk 43 ). Native proteins are advantageous in that they are biologically tuned to respond under physiological conditions and the function of critical protein regions are typically well described.
Here we used existing knowledge of the FoxO1 sequence to optimize an existing FoxO1 reporter. Specifically, we increased specificity by both targeting a large peptide region for deletion that is not involved in nuclear translocation and by modifying multiple phosphorylation sites that are not phosphorylated by Akt. Additionally, we optimized nuclear export through the modification of a short peptide sequence. These modifications would have been difficult to predict in the absence of previous studies. For example, nuclear export was improved by substitution of a phospho-mimetic amino acid rather than an alanine at serine 326, and export was further aided by mutating the surrounding amino acids to better match the charge from phosphorylation 30, 31 . All together these modifications significantly increased the specificity of the reporter for IGF-I signaling in HeLa cells, and allowed for increased accuracy in tracking individual cell responses. Our approach outlined here, which considers putative phosphorylation sites to develop and optimize the FoxO1 reporter, could be used to efficiently develop reporters targeting other signaling pathways.
Channel capacity quantification
Previous studies of the Erk, NFkB, and Ca 2+ signaling pathways have found channel capacities from 1-1.7 bits 2, 3, 5, 44 . Here, we assessed the channel capacity of the PI3K-AKT pathway using IGF-I. Importantly, this growth factor produces sustained Akt signaling responses 45 , making it simpler to quantify and identify signaling patterns across time. We found that using a single time point to quantify channel capacity yielded a value of 1 bit, which was increased to 1.4 bits by normalizing responses and incorporating measures from multiple time points. These values are in line with previous measures on other signaling pathways 2, 3, 5, 44 . We further refined our calculations by considering that single cell responses are sustained over time and do not show large fluctuations. Thus, rather than using the heterogeneity in the extent of responses, which could be from differences in how individual cells encode the IGF-I signal, we used the variance across time once cells had reached a steady state in their response. We used this metric for variance in the Shannon-Hartley formula, which increased the calculated channel capacity to 2.38 bits (~5 doses), nearly double previous calculations for other pathways. Considering that each cell has its own communication channel, rather than the population having a single noisy communication channel, revealed high signaling fidelity. Based on these results, we hypothesize that other signaling pathways may also have a much higher signaling fidelity then previously reported.
Multi-treatment experiments reveal variation in single cell responses
The ability to quantify responses to multiple treatments in individual cells provides a powerful technique for understanding mechanisms of population variation 46, 47 . This is in stark contrast to standard experiments in which single measures on individual cells are drawn from different populations, or the response to only a single stimulus is tracked across time. We used this multitreatment approach to achieve several means: first we used LMB normalization to quantify the measurement range of the reporter and to show that individual cell responses are not biased by the level of reporter expression, second we used multi-dose IGF-I treatments to validate that cells can accurately discriminate multiple doses of IGF-I and to identify variability in IGF-I encoding across the population, and third we used activation-inhibition experiments to determine that the level of signaling activity in an individual cell biases the extent of inhibition.
Without these multiple measurements, it would not be possible to identify these patterns nor quantify potential sources of biological variation.
Cells exist in different states with different input-output relationships
Our data indicate that cells can accurately interpret multiple growth factor signals in their extracellular environment and that across the population there is variation in how cells encode this signal. As a consequence, it is not possible to decode the input based on a single response.
It is only through knowledge about how a cell responds to a second perturbation-either activation or inhibition-that the input signal could be decoded. This raises the question of what cellular parameter varies to create different input-output relationships across the population. It is reasonable to assume that variation in the input-output relationships between cells occurs because they differ in the content of the IGF-I receptor or another pathway component 48 , but it could also be from differences in basal signaling 49 , cell shape 50 , nuclear import/export machinery 38 , or phosphatase activity. Assessing each of these mechanisms is experimentally difficult, but our work suggests that it may be possible to tease apart these different mechanisms using a multi-treatment approach.
Our studies indicate that signaling responses to molecules that activate or inhibit the IGF-I-AKT signaling pathway are not necessarily noisy. This is important as it rules out one mechanism for drug resistance: that cells have large and variable signaling fluctuations that allow them to overcome inhibition. This conclusion also suggests a role for microenvironmental signals to modulate therapeutic response. For instance, subpopulations of cells may be subject to signals that lead to pathway activation, whereby a larger drug dose may be required to fully inhibit these cells 19, 51 . These experiments open the door to more in depth studies on how various pathway inhibitors alter signaling activity and how treatments regimens could be optimized for use in the clinic, particularly in the metastatic setting where cancer cells have disseminated to distinct tissue sites enriched with unique complements of signaling molecules.
Summary
A significant question in cell biology is how much noise is present in a signaling pathway, and as a consequence how accurately a signal can be interpreted and processed. Along with the development of an improved reporter, we found that individual cells can accurately interpret multiple IGF-I concentrations, although each cell encodes the signal differently. This conclusion has significant impacts on how we think about the regulation of biochemical pathways and cellcell heterogeneity.
METHODS
Cloning
The new FoxO1-Clover reporter was constructed from a modified pSBbi-RP plasmid 28 
Transfection and selection of stable cell lines
Reporter Characterization
To characterize each HeLa reporter cell line, cells were serum starved for 90 minutes in Fluorobrite media (ThermoFisher) supplemented with 2 mM L-glutamine, 0.1% bovine serum albumin, penicillin and streptomycin. Cells were then treated with 250 pM R3-IGF-I for 90 minutes followed by the combined addition of the dual PI3K and mTOR inhibitor PI-103 (1 µM) and LMB (100 nM) for 90 minutes. From these experiments, we quantified: the average rate of reporter nuclear exclusion following IGF-I treatment, the average rate of nuclear localization following PI-103 and LMB, and the average measurement range, which was defined as the difference between the percent nuclear localization after serum starvation and the percent nuclear localization 90 min after IGF-I treatment. Export and import rates were calculated using the population average response and fit via non-linear regression (Graph Pad Prism 7). All cell lines were imaged using the same 75 millisecond imaging duration.
IGF-I single and multi-dose experiments
For IGF-I dose response experiments, HeLa cells were plated in 12-well plates (Falcon) allowed to grow for 48 h and then serum starved for 90 min in imaging media. Cells were then treated with: 0, 5, 10, 15, 20, 25, 30, 40 50, 75, 125, 
Alpelisib experiments.
For tracking cell responses to PI3Kα inhibition, cells were serum starved for 90 min and then treated with either 0, 25, or 125 pM R3-IGF-I. After treatment for 90 min cells were exposed to 0, 12.5, 25, 37.5, 250, or 500 nM alpelisib for 90 min.
Quantification of channel capacity
Channel capacity was calculated using the Shannon-Hartley formula: CC = ½ log 2 (S 2 /N 2 ), where CC is the channel capacity in bits, S is the signal magnitude quantified by taking the variance of the average response across six relatively evenly spaced IGF-I doses representing the full dose range (0, 10, 15, 25, 40, 125 pM R3-IGF-I), and N is the noise magnitude quantified by taking the average variance within a dose and averaging across all doses 3 .
Data Availability
Source data are available from the corresponding author upon reasonable request. 
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